Craniopharyngiomas and proton beam therapy: worth the expense?

Affiliations

¹ Barts and the London School of Medicine, University of London, London, UK; Green Templeton College, University of Oxford, Oxford, UK. Electronic address: ashley.grossman@ocdem.ox.ac.uk.
² Department of Radiotherapy, University College London Hospitals NHS Foundation Trust, London, UK.

Comment

Ashley Grossman et al. Lancet Oncol. 2023 May.

. 2023 May;24(5):422-423.

doi: 10.1016/S1470-2045(23)00162-6. Epub 2023 Apr 18.

¹ Barts and the London School of Medicine, University of London, London, UK; Green Templeton College, University of Oxford, Oxford, UK. Electronic address: ashley.grossman@ocdem.ox.ac.uk.
² Department of Radiotherapy, University College London Hospitals NHS Foundation Trust, London, UK.

No abstract available

Conflict of interest statement

We declare no competing interests.

Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR): a single-arm, phase 2 study.
Merchant TE, Hoehn ME, Khan RB, Sabin ND, Klimo P, Boop FA, Wu S, Li Y, Burghen EA, Jurbergs N, Sandler ES, Aldana PR, Indelicato DJ, Conklin HM. Merchant TE, et al. Lancet Oncol. 2023 May;24(5):523-534. doi: 10.1016/S1470-2045(23)00146-8. Epub 2023 Apr 18. Lancet Oncol. 2023. PMID: 37084748 Free PMC article. Clinical Trial.